Sofi Lehtinen

Parties

Faron Pharmaceuticals Ltd

Transaction

Hannes Snellman acted as counsel to Faron Pharmaceuticals Ltd in its public share offering of EUR 30.7 million and the preceding issuance of convertible capital loans in the total amount of EUR 3.2 million and a private placement of EUR 4.8 million. Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatment of cancers via novel immunotherapies. Faron’s shares are listed on Nasdaq First North Growth Market Finland and as depositary interests, representing entitlements to shares, on AIM in the United Kingdom. The offering consisted of a public offering to private individuals and legal entities in Finland and an institutional offering to institutional investors internationally, and a separate open offer to qualifying holders of depositary interests in the United Kingdom and elsewhere and a retail offer to retail investors in the United Kingdom.

Deal Value

EUR 30.7 million

Role

Counsel to Faron Pharmaceuticals Ltd

Parties

Sampo plc and Topdanmark A/S

Transaction

Sampo plc's recommended public exchange offer for the shares in Topdanmark A/S

Deal Value

DKK 33 billion

Role

Counsel to Sampo plc

Transaction 

Counsel to YIT Oyj in relation to its EUR 33.5 million directed share issue, its issue of EUR 36 million convertible notes and certain amendments to its EUR 300 million revolving credit facility agreement with Nordea, Danske Bank, LähiTapiola, OP Corporate Bank, SEB, and Swedbank and its EUR 140 million term loan facility agreement with OP Corporate Bank, SEB, and Swedbank.

Role

Counsel to YIT Oyj

Parties:

Kemppi Group Oy, Kempower Corporation

Transaction:

Counsel to Kemppi Group Oy, the majority owner of Kempower Corporation, in the placing of 3.4 million shares in Kempower Corporation

Deal value:

EUR 102 million

Role:

Counsel to Kemppi Group Oy

Parties:

Terveystalo Plc

Transaction: 

Counsel to Terveystalo Plc, a healthcare service provider listed on Nasdaq Helsinki, in the issue and listing of senior unsecured sustainability-linked notes. 

Value:

EUR 100 million

Role:

Counsel to Terveystalo Plc

Parties:

Sega Europe Limited and SEGA Corporation (Buyers) Rovio Entertainment Corporation (Target)

Transaction:

Counsel to Sega Europe Limited and SEGA Corporation in the recommended public cash tender offer for all shares and options in Rovio Entertainment Corporation.

Deal value: 

Approximately EUR 706 million

Role:

Counsel to Sega Europe Limited and SEGA Corporation

Parties

Citycon Oyj

Transaction

Counsel to Citycon Oyj in its tender offers of outstanding notes due 2024 of Citycon Treasury B.V. and capital securities issued by it in November 2019 and June 2021.

Deal value

Over EUR 40 million

Role

Counsel to Citycon Oyj

Counsel to F-Secure on its spin-off and listing on Nasdaq Helsinki.

Parties

The German State (Buyer), Fortum Oyj (Seller), Uniper SE (Target)

Transaction 

Fortum Oyj’s arrangements related to stabilisation of its German subsidiary Uniper SE. The package will ensure multi-billion funding for Uniper, sale of Fortum’s shareholding in Uniper to the German State for approximately EUR 0.5 billion as well as repayment of Fortum’s EUR 4 billion receivables from Uniper and release of EUR 4 billion parent company guarantees.

Deal value 

Approx. EUR 4.5 billion

Role 

Finnish counsel to Fortum Oyj

Parties

Valmet, Neles

Transaction

Hannes Snellman acted as lead counsel to Valmet, a leading global developer and supplier of process technologies, automation, and services for the pulp, paper, and energy industries, in its merger with Neles, one of the leading providers of mission-critical flow control solutions and services for process industries in Finland. 

Deal Value

The combined value of the merging companies is approximately EUR 7 billion.

Role

Lead counsel to Valmet

Parties

Virala Acquisition Company Plc

Transaction

Hannes Snellman acted as legal counsel to Virala Acquisition Company Plc on its IPO and the listing of its Class C shares on the SPAC segment of the regulated market of Nasdaq Helsinki

Deal Value

EUR 107.5 million

Role

Counsel to Virala Acquisition Company Plc